Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Linkest Limited Announces Official Launch of Bespoke Lab-Grown Diamond Jewelry Line

April 15, 2026

BRIDGE Alliance Expands Summit to Five Days as It Scales Global Media Platform

April 14, 2026

Kelowna woman gets second chance at life thanks to complete stranger

April 14, 2026

Sony’s new 1440p OLED gaming monitor seems a lot better than its first

April 14, 2026

Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe

April 14, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe
Press Release

Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe

By News RoomApril 14, 20262 Mins Read
Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe
Share
Facebook Twitter LinkedIn Pinterest Email

COPENHAGEN, Denmark, April 14, 2026 (GLOBE NEWSWIRE) — Arla Foods Ingredients has developed high-protein, nutrient-dense application concepts for users of GLP-1 anti-obesity medications, which it will showcase at Vitafoods Europe (5th-7th May 2026 in Barcelona).

Originally developed to treat diabetes, GLP-1 receptor agonists have re-shaped the weight management market. In 2025, 11% of consumers globally [1] and 18% in the US [2] who were actively trying to lose weight reported using them, with uptake expected to rise as availability expands, tablet formats emerge and prices fall [3].

However, GLP-1 use is associated with side effects: lean muscle loss may reach 40% of total mass lost, versus around 25% with traditional interventions [4, 5, 6], while up to 76% of GLP-1 consumers report gastric discomfort and reduced appetite [7].

To help manufacturers address these needs, Arla Foods Ingredients has developed high-protein concepts with Nutrilac® and Lacprodan® BLG-100, delivering all essential amino acids for muscle health in nutrient-dense formats, and incorporating probiotics / cultures from Novonesis to support digestive well-being. 

The range includes great-tasting formats for reduced appetites:

  • A fermented, high-protein shot featuring Nutrilac® ProteinBoost, offering 10g of protein per 70ml serving; low fat, lactose-reduced and no added sugar.
  • A fermented, high-protein drinking yoghurt featuring Nutrilac® ProteinBoost and Nutrilac® MFGM, providing 20g protein per 200ml serving; lactose-reduced.
  • A fermented, high-protein spoonable yoghurt featuring Nutrilac® ProteinBoost, Nutrilac® YO-7700, and Capolac® milk minerals, providing 20g protein per 120g serving; high in calcium, low fat and lactose-reduced.
  • A high-protein water-based shot for ambient storage, featuring Lacprodan® BLG-100 and providing 21g of protein per 100ml serving; fat-free, sugar-free and low in lactose.

Anne Widart, Chief Commercial Officer of Arla Foods Ingredients, said: “Nutrition for GLP-1 users is a growing category, creating opportunities for dairy manufacturers. There is increasing demand for nutrient-dense, high-protein products in formats suited to smaller appetites. Our concepts are designed to help manufacturers respond to these evolving needs.”

Arla Foods Ingredients will showcase the GLP-1 companion nutrition solutions at Vitafoods Europe (Stand #3G156) alongside two additional concepts:

  • An aerated protein bar solution made with Nutrilac® PB-8420, offering high-quality milk protein and a light, soft texture enabled by stable air incorporation during processing and shelf life.
  • Ready-to-stir medical nutrition powder solutions made with Lacprodan® BLG-100 Acidic, combining a refreshing taste, no bitterness and low astringency, low viscosity at high protein levels, and good solubility in water, foods and drinks.

Photo https://www.globenewswire.com/NewsRoom/AttachmentNg/debb0da5-3fc7-43ee-93f7-b975d7eab6b0

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Linkest Limited Announces Official Launch of Bespoke Lab-Grown Diamond Jewelry Line

BRIDGE Alliance Expands Summit to Five Days as It Scales Global Media Platform

Movement Integrates Avant to Unlock Institutional-Grade Yield for Everyday Users

American Addiction Centers and Filmmaker Jeffrey Shulman Team Up to Promote Powerful New Film on Addiction and Recovery with National Theatrical Tour

Albertsons Reaches $774 Million Opioid Settlement with State, Local and Tribal Governments; Levin Papantonio Attorneys Among Legal Team Driving Pharmacy Accountability

At Auto China 2026, HERE showcases AI-powered mapping technology powering Chinese automakers worldwide

SMB Value Investing Group Launches Platform Giving Accredited Investors Access to Institutional-Quality Small Business Acquisitions

Northrop Grumman’s B-21 Raider Powers Unmatched Long-Range Strike Capability

Neion Bio Strengthens Genome Engineering Leadership with Appointment of Colossal Biosciences Veteran James Kehler

Editors Picks

BRIDGE Alliance Expands Summit to Five Days as It Scales Global Media Platform

April 14, 2026

Kelowna woman gets second chance at life thanks to complete stranger

April 14, 2026

Sony’s new 1440p OLED gaming monitor seems a lot better than its first

April 14, 2026

Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe

April 14, 2026

Latest News

Bell holds closed-door meeting with Saskatchewan landowners over AI data centre

April 14, 2026

Chrome now lets you turn AI prompts into repeatable ‘Skills’

April 14, 2026

Movement Integrates Avant to Unlock Institutional-Grade Yield for Everyday Users

April 14, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version